Professional development Vacancies

The International Coalition of Medicines Regulatory Authorities (ICMRA)

28.08.2023 Updated 18.01.2024 1357 views

The International Coalition of Medicines Regulatory Authorities is the most influential format of interaction among the heads of regulatory authorities in the field of medicinal product circulation in different countries of the world. The State Expert Center has cooperated with ICMRA since 2021 as an Associate Member.

Representation in the coalition is carried out at the highest level. Since becoming a member, Director Mykhailo Babenko and the Center's specialists have actively participated in summits, forums, plenary sessions, conferences, seminars, workshops, and other ICMRA events and activities, in particular in the following areas:

  • pharmacovigilance;
  • antimicrobial resistance (AMR);
  • drug shortage;
  • innovations;
  • convergence of regulatory and legal approaches;
  • crisis management (coordination of the response of regulatory authorities to COVID-19 at the global level);
  • pharmaceutical product quality knowledge management system (PQ KMS).

Such interaction helps strengthen dialogue with competent authorities around the world, prompt exchange of reliable and comparable information, shared use of resources and work results, coordinated response to crisis situations, and timely response to current and emerging issues in the regulation and safety of medicinal products for human use.

ICMRA was established in 2012 at the 65th session of the World Health Assembly. Among its main tasks: to promote better protection of public health by enabling heads of regulatory authorities to provide collective and coordinated strategic leadership of existing and new international initiatives, and to engage them in addressing common regulatory issues and challenges faced by the global pharmaceutical industry.

Read more here